A program in a multifacility health care system is designed to enhance early detection of lung cancer through follow-up of nodules seen on thoracic imaging studies.
A new injectable agent causes cancer cells in a tumor to fluoresce, potentially enabling surgeons to locate and remove all of a cancerous tumor on the first attempt.
Ultrasound has comparable sensitivity in detecting breast cancer compared with mammography and should be considered when testing for the disease.
Additional breast cancers found with MRI are sometimes larger and potentially more aggressive than those found on mammography, and in some cases, may necessitate a change in treatment plan.
A method to better trace changes in cancers and treatment of the prostate and lung without the limitations associated with radiation has been developed.
An FDA-approved, magnetic nanoparticle and MRI identifies tumors most likely to respond to drugs delivered via nanoparticles.
Women with a certain type of lung nodule visible on lung cancer screening CT scans face a higher risk of lung cancer than men with similar nodules, according to a study presented at RSNA 2015.
With some training and selective food reinforcement, pigeons performed as well as humans in categorizing digitized slides and mammograms showing benign and malignant human breast tissue.
American College of Radiology (ACR) Releases Updated Appropriateness Criteria, Including 3 New CriteriaNovember 13, 2015
American College of Radiology updated its Appropriateness Criteria for 19 topics, including 3 new criteria. These guidelines assist clinicians in the most efficacious use of radiology.
Risks in LDCT Lung Cancer Screenings Need to be Assessed Before Expanding Eligibility to Persons With Lower Smoking HistoriesNovember 09, 2015
The potential risks and harms of LDCT lung cancer screening in current 20- to 29-pack-year smokers needs to be assessed before recommending LDCT for this group.
A new laser-based microscope technology may help surgeons see the difference between tumor tissue and normal brain tissue in real-time.
In a study conducted to inform American Cancer Society (ACS) breast cancer screening guidelines, a screening mammography once every 2 years was found to be safe for postmenopausal women at average risk of breast cancer.
Imaging Method Has Potential to Predict Effectiveness of Induction Chemotherapy in Patients With Head and Neck CancerOctober 01, 2015
Researchers identified a potential new way to predict which patients with head and neck cancer will benefit most from chemotherapy.
Low-risk cancers that are asymptomatic and presumably will not cause problems in the future are responsible for the rapid increase in the number of new thyroid cancer diagnoses over the past decade, according to a study.
Researchers have discovered that determining a tumor's medulloblastoma subgroup can be achieved noninvasively, using magnetic resonance spectroscopy (MRS).
Researchers have developed a magnetic resonance imaging (MRI) contrast agent with the capability to pinpoint much smaller aggressive breast cancer tumors and micrometastases.
New molecular tools are emerging to identify lung adenocarcinomas during pulmonary resection. The results of a proof-of-concept study suggest that fluorescent imaging of lung cancer during surgery using targeted molecular agents may soon be a reality.
Classification system offers precise determination of effectiveness of surgical resection of gliomasAugust 11, 2015
A new procedure for analyzing radiologic imaging scans increases the chance to accurately predict the course of malignant gliomas.
With the availability of tomosynthesis mammography, should women at high risk for developing breast cancer still undergo annual MRI?
BALTIMORE, MD—For more aggressive cases of non-Hodgkin lymphoma (NHL), posttreatment surveillance with molecular imaging could mean the early start of a new, life-saving treatment. This was presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 Annual Meeting.
A new, accurate imaging technique, combining photoacoustics with nanosensors, has been developed for the noninvasive screening of lymph nodes for metastatic cancer.
Preoperative navigated transcranial magnetic stimulation (nTMS) analysis of motor areas can improve the prognosis for patients with malignant brain tumors.
PET-CT guided active surveillance for patients with locally advanced head and neck squamous cell cancer is an option over node dissection, per analysis data presented at the 2015 American Society of Clinical Oncology annual meeting.
Magnetic resonance imaging (MRI) can provide vital information for predicting the odds of breast cancer development.
Tomosynthesis detects 40% more breast cancers than traditional mammography does, according to a major screening study.
Digital breast tomosynthesis increases the rate of cancer detection in women with dense breast tissue by as much as 67%, according to research.
Although FDG PET/CT is appropriate for systemic staging of newly diagnosed stage III breast cancer, the technique may not be equally valuable for all breast cancer histologies, research indicates.
A magnetic resonance imaging (MRI)-based screening program for persons at high risk of pancreatic cancer identified pancreatic lesions in 40% of patients, according to an online report.
For men with nonmetastatic castration resistant prostate cancer with a negative bone scan after diagnosis, factors associated with a second bone scan include higher PSA, shorter PSA doubling time, and faster PSA velocity; but under- and over-imaging may also be a factor.
Study data suggests that magnetic resonance imaging (MRI) could one day make biopsies more effective, or even replace them altogether, via noninvasive detection of telltale sugar molecules shed by the outer membranes of cancerous cells.
- Prostate-Specific Antigen (PSA) Test (Fact Sheet)
- Inconclusive: The Pulmonary Nodules You Need to Follow
- Proposed Regimen for Ovarian Cancer Is Aggressive, But Could Achieve a 50% Cure Rate
- Better Approaches to Patient Counseling of BRCA Gene Mutation Carriers Needed
- Novel Procedure Improves Staging of Lymph Nodes in Patients With Breast Cancer
- Low-income Breast Cancer Survivors Benefit From Personalized Survivorship Care Plans
- Understanding Drug Naming Nomenclature
- Nurse Navigators Key to Seamless Transition From Pediatric to Adult Survivorship Care
- Inconclusive: The Pulmonary Nodules You Need to Follow
- Common Painkiller Has Anticancer Effects
- Risk of Breast Cancer or Thyroid Cancer Higher Following a Diagnosis of the Other Cancer Type
- HIV and Cancer: Dual Diagnosis Compounds Challenges in Coping
- Cola Consumption May Increase Erlotinib Absorption in Patients Taking PPIs
- Proton Beam Therapy Treats Childhood Brain Cancer as Effectively as Standard Radiation
- Risk of Ovarian Cancer Predicted With Fine-tuned Test
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|